Carbidopa impurity F
CAS: 1458640-32-8
Ref. 3D-FH177492
1mg | 194,00 € | ||
2mg | 310,00 € | ||
5mg | 436,00 € | ||
10mg | 647,00 € | ||
25mg | 986,00 € |
Información del producto
- (αS)-α-Hydrazinyl-3,4-dihydroxy-α-methylbenzenepropanoic acid ethyl esterCarbidopa EP impurity F
Carbidopa is an impurity of the drug L-DOPA, which is used as a treatment for Parkinson's disease. Carbidopa is a prodrug that is converted to L-DOPA by decarboxylase, an enzyme in the body. The conversion process can be inhibited by the presence of carbidopa impurity F (CIF), which binds to carboxamides and forms a stable complex with them. This prevents CIF from binding to decarboxylase and blocking its ability to convert carbidopa into L-DOPA. CIF has been shown to have anti-parkinsonian effects by reducing the severity of symptoms associated with Parkinson's disease such as muscular rigidity and tremors.
Propiedades químicas
Consulta técnica sobre: 3D-FH177492 Carbidopa impurity F
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.